Specificity of the Calgary Depression Scale for schizophrenics
- PMID: 8193062
- DOI: 10.1016/0920-9964(94)90017-5
Specificity of the Calgary Depression Scale for schizophrenics
Abstract
This study sought to determine the specificity of the Calgary Depression Scale (CDS), a depression rating scale for schizophrenics. The specificity is the degree to which the scale assesses depression rather than negative or extrapyramidal symptoms. Subjects were 100 outpatients (OP) and 50 inpatients (IP) meeting DSM-III-R criteria for schizophrenia. Negative symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS); extrapyramidal symptoms were assessed with the Simpson Angus Scale (SA) and depression with the CDS. Results were that the CDS showed no correlation with SA, but weak (0.33) statistically significant correlations with the PANSS negative symptom score in inpatients but not outpatients. Confirmatory factor analysis using Lisrel 6.0 showed that the model hypothesizing specificity of depression, negative symptoms and extrapyramidal symptoms, was significant, with a goodness of fit index of 0.89 and a root mean square residual of 0.07. It is concluded that the CDS achieves a useful degree of separation between measures of depression, negative and extrapyramidal symptoms in subjects with schizophrenia, when combined with the other measures used in this study.
Similar articles
-
Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).J Affect Disord. 2000 May;58(2):107-15. doi: 10.1016/s0165-0327(99)00075-0. J Affect Disord. 2000. PMID: 10781700
-
Depression in schizophrenia: a comparison of three measures.Schizophr Res. 1996 May;20(1-2):205-9. doi: 10.1016/0920-9964(95)00107-7. Schizophr Res. 1996. PMID: 8794511
-
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5. Schizophr Res. 2004. PMID: 15099616
-
[Depressive symptoms and negative symptoms during schizophrenia].Encephale. 1995 Jun;21 Spec No 3:23-7. Encephale. 1995. PMID: 7628337 Review. French.
-
[Instruments of depression assessment in schizophrenia].Actas Esp Psiquiatr. 2001 Jul-Aug;29(4):259-68. Actas Esp Psiquiatr. 2001. PMID: 11470061 Review. Spanish.
Cited by
-
Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.J Clin Psychiatry. 2011 Jan;72(1):75-80. doi: 10.4088/JCP.09m05258gre. Epub 2010 Sep 21. J Clin Psychiatry. 2011. PMID: 20868641 Free PMC article. Clinical Trial.
-
Behavioral outputs of negative symptom domains of schizophrenia.Exp Ther Med. 2021 Aug;22(2):805. doi: 10.3892/etm.2021.10237. Epub 2021 May 26. Exp Ther Med. 2021. PMID: 34093761 Free PMC article.
-
Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):387-96. doi: 10.1007/s00406-016-0697-2. Epub 2016 Apr 23. Eur Arch Psychiatry Clin Neurosci. 2016. PMID: 27107764
-
Co-morbid PTSD and suicidality in individuals with schizophrenia and substance and alcohol abuse.Soc Psychiatry Psychiatr Epidemiol. 2011 Nov;46(11):1079-86. doi: 10.1007/s00127-010-0277-0. Epub 2010 Aug 15. Soc Psychiatry Psychiatr Epidemiol. 2011. PMID: 20711764
-
The relationship between depressive syndrome and suicidal risk in patients with acute schizophrenia.Croat Med J. 2013 Oct 28;54(5):436-43. doi: 10.3325/cmj.2013.54.436. Croat Med J. 2013. PMID: 24170722 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous